These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 17159717)

  • 41. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
    Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
    J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Capillary abnormalities, Raynaud's phenomenon, and systemic sclerosis in patients with localized scleroderma.
    Maricq HR
    Arch Dermatol; 1992 May; 128(5):630-2. PubMed ID: 1575525
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic Sclerosis Sine Scleroderma.
    Manoria P; Joshi P; Sharma P; Jha RK
    J Assoc Physicians India; 2014 Dec; 62(12):54-6. PubMed ID: 26259425
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical and capillaroscopic regression of CD30 anaplastic lymphoma associated with limited cutaneous systemic sclerosis following autologous bone marrow transplantation].
    Bellis R; Francès C; Barète S; Senet P
    Ann Dermatol Venereol; 2014; 141(6-7):446-51. PubMed ID: 24951144
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Application of the 2013 ACR/EULAR classification criteria for systemic sclerosis to patients with Raynaud's phenomenon.
    Park JS; Park MC; Song JJ; Park YB; Lee SK; Lee SW
    Arthritis Res Ther; 2015 Mar; 17(1):77. PubMed ID: 25889905
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Epidemiology of systemic sclerosis.
    Nikpour M; Stevens WM; Herrick AL; Proudman SM
    Best Pract Res Clin Rheumatol; 2010 Dec; 24(6):857-69. PubMed ID: 21665131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Antiendothelial antibodies in systemic scleroderma and Raynaud's disease].
    Salozhin KV; Shcherbakov AB; Nasonov EL; Kolesova NV; Romanov IuA; Guseva NG
    Ter Arkh; 1995; 67(5):54-7. PubMed ID: 7638782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic significance of Raynaud's phenomenon and other clinical characteristics of systemic scleroderma. A study of 271 cases.
    FARMER RG; GIFFORD RW; HINES EA
    Circulation; 1960 Jun; 21():1088-95. PubMed ID: 13821594
    [No Abstract]   [Full Text] [Related]  

  • 49. A Delphi exercise and cluster analysis to aid in the development of potential classification criteria for systemic sclerosis using SSc experts and databases.
    Coulter C; Baron M; Pope JE
    Clin Exp Rheumatol; 2013; 31(2 Suppl 76):24-30. PubMed ID: 23557780
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Classification of Japanese patients with mild/early systemic sclerosis (SSc) by the 2013 ACR/EULAR classification criteria for SSc.
    Ikawa Y; Hamaguchi Y; Mugii N; Matsushita T; Takehara K
    Mod Rheumatol; 2017 Jul; 27(4):614-617. PubMed ID: 27830961
    [TBL] [Abstract][Full Text] [Related]  

  • 51. RNA polymerase III autoantibodies may indicate renal and more severe skin involvement in systemic sclerosis.
    Terras S; Hartenstein H; Höxtermann S; Gambichler T; Kreuter A
    Int J Dermatol; 2016 Aug; 55(8):882-5. PubMed ID: 26499848
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [An elderly woman with stiffness of the thumb].
    Franssen LE; Franssen MJ; Jeurissen M
    Ned Tijdschr Geneeskd; 2012; 156(47):A4550. PubMed ID: 23171559
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Scleroderma patients nailfold videocapillaroscopic patterns are associated with disease subset and disease severity.
    Caramaschi P; Canestrini S; Martinelli N; Volpe A; Pieropan S; Ferrari M; Bambara LM; Carletto A; Biasi D
    Rheumatology (Oxford); 2007 Oct; 46(10):1566-9. PubMed ID: 17693443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S; Dostrovsky N; Hudson M; Tatibouet S; Fritzler MJ; Baron M; Khalidi N;
    J Rheumatol; 2014 Nov; 41(11):2179-85. PubMed ID: 25274885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic sclerosis sine scleroderma and limited cutaneous systemic sclerosis: similarities and differences.
    Simeón-Aznar CP; Tolosa-Vilella C; Gabarró-Juliá L; Campillo-Grau M; Guillén Del Castillo A; Fonollosa-Plá V; Vilardell-Tarrés M
    Clin Exp Rheumatol; 2014; 32(6 Suppl 86):S-33-40. PubMed ID: 24776173
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Raynaud's syndrome and scleroderma. I. Scleroderma-like changes in Raynaud's syndrome and their differentiation from scleroderma].
    JABLONSKA S; LUKASIAK B; BUBNOW B
    Pol Tyg Lek (Wars); 1957 Sep; 12(39):1481-6. PubMed ID: 13505250
    [No Abstract]   [Full Text] [Related]  

  • 57. Longitudinal study of patients with anticentromere antibody.
    Takehara K; Soma Y; Igarashi A; Kikuchi K; Tamaki T; Ishibashi Y
    Dermatologica; 1990; 181(3):202-6. PubMed ID: 2135387
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Organ manifestations in 100 patients with progressive systemic sclerosis: a comparison between the CREST syndrome and diffuse scleroderma.
    Akesson A; Wollheim FA
    Br J Rheumatol; 1989 Aug; 28(4):281-6. PubMed ID: 2787182
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic sclerosis sine scleroderma.
    Kucharz EJ; Kopeć-Mędrek M
    Adv Clin Exp Med; 2017 Aug; 26(5):875-880. PubMed ID: 29068586
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The prognosis of systemic sclerosis.
    Rowell NR
    Br J Dermatol; 1976 Jul; 95(1):57-60. PubMed ID: 952740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.